Dementia

FILE - In this Aug. 14, 2018 file photo, a doctor looks at PET brain scans in Phoenix. A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing emergency room visits and hospitalizations. The results announced Thursday, July 30, 2020 call into question whether the costly tests are worth it for a disease that currently has no cure. (AP Photo/Matt York, File)
1010 WINS Newsroom
July 30, 2020 - 9:35 am
A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing health care costs, calling into question whether the pricey tests are worth it. The results announced Thursday are from a $100 million study of more than...
Read More
In this image from video provided by Washington University, researcher Nicolas Barthelemy works on a p-tau217 test for Alzheimer's disease at a laboratory in St. Louis, Mo., on Monday, July 27, 2020. Several companies and universities have developed versions of these tests, which look for a form of tau protein, one of the substances that can build up and damage the brains of people with Alzheimer’s. (Huy Mach/University of Washington via AP)
1010 WINS Newsroom
July 28, 2020 - 1:11 pm
An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia. Developing such a test has been a long-sought goal, and...
Read More
President Donald Trump calls on members of the press during a news conference at the White House, Tuesday, July 21, 2020, in Washington. (AP Photo/Evan Vucci)
1010 WINS Newsroom
July 24, 2020 - 6:15 am
WASHINGTON (AP) — It doesn’t quite have the ring of “Morning in America” and “I Like Ike.” But the phrase “Person. Woman. Man. Camera. TV.” is getting an unlikely moment in the spotlight as President Donald Trump has taken a detour into the politics of dementia three months before the election...
Read More
The Canyon Creek Memory Care Community is seen in Billings, Mont. on Friday, July 10, 2020. The facility that cares for people with dementia and other cognitive issues has seen at least seven deaths since a coronavirus outbreak sickened almost all its residents and many staff members. The Montana memory care facility that didn't carry out no-cost COVID-19 testing on its residents is reeling from an outbreak that has sickened more than 50 residents and 36 staff. (AP Photo/Matthew Brown)
1010 WINS Newsroom
July 14, 2020 - 2:25 pm
BILLINGS, Mont. (AP) — It was meant to be a last line of defense to protect the most vulnerable as the coronavirus spread across the United States: Montana officials offered free testing in May for staff and residents at assisted living and long-term care facilities. But not all of them followed...
Read More
In this photo taken on Wednesday, April 29, 2020, Diane Wanten, 61, left, walks with her son Federico after being discharged from the Jessa Hospital in Hasselt, Belgium. Wanten was released from the hospital into home quarantine after being treated for two weeks in an ICU ward for COVID-19 coronavirus patients. (AP Photo/Francisco Seco)
1010 WINS Newsroom
May 01, 2020 - 2:28 am
ALKEN, Belgium (AP) — Sucking in the little oxygen her lungs could still process, Diane Wanten wouldn't back down in her fight against a disease that is killing tens of thousands a week around the globe. Too much was still waiting for her. “It kept turning in my head: I need to survive this. I...
Read More
An exterior view of the Supreme Court in The Hague, Netherlands, Tuesday, April 21, 2020. The Netherlands' highest court ruled Tuesday that doctors can carry out euthanasia in patients with advanced dementia if the patient has earlier made a written directive. The Supreme Court ruling solidifies in law a practice that already was being carried out on rare occasions in the Netherlands. (AP Photo/Mike Corder)
1010 WINS Newsroom
April 21, 2020 - 10:34 am
THE HAGUE, Netherlands (AP) — The Netherlands' highest court ruled Tuesday that doctors can carry out euthanasia in patients with advanced dementia if the patient has earlier made a written directive. The Supreme Court ruling solidifies in law a practice that already was being carried out on rare...
Read More
In this March 11, 2020, photo, Kalianthi Karipidu, 89, poses for a photo at the windows of her home in central Rome. Italy has one of the world’s oldest populations, and the coronavirus outbreak is taking its toll on family relationships. The elderly are sealing themselves off from loved ones or can’t be visited due to nursing home rules or travel restrictions. (AP Photo/Alessandra Tarantino)
1010 WINS Newsroom
March 12, 2020 - 6:20 am
ROME (AP) — Natalina De Santis’ three adult children come to her front door, bringing food to keep her healthy and books to relieve her boredom, but she doesn’t let them in any more. Widowed a few months ago and living alone, the 83-year-old resident of Rome is so afraid of catching the coronavirus...
Read More
1010 WINS Newsroom
February 07, 2020 - 12:37 pm
AMSTERDAM (AP) — A Dutch organization that carries out euthanasia received 3,122 requests last year, a 22% increase from the year before, the Euthanasia Expertise Center said Friday. “Every work day, 13 people say: 'Help me, I can’t go on,'” Steven Pleiter, director of the center formerly known as...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
1010 WINS Newsroom
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More

Pages